118 related articles for article (PubMed ID: 26934442)
1. Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC.
Gilormini M; Malesys C; Armandy E; Manas P; Guy JB; Magné N; Rodriguez-Lafrasse C; Ardail D
Oncotarget; 2016 Mar; 7(13):16731-44. PubMed ID: 26934442
[TBL] [Abstract][Full Text] [Related]
2. Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit.
Johnson DE
Chin J Cancer; 2012 Jul; 31(7):319-26. PubMed ID: 22257382
[TBL] [Abstract][Full Text] [Related]
3. The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma.
Shah A; Patel S; Pathak J; Swain N; Kumar S
ScientificWorldJournal; 2014; 2014():842491. PubMed ID: 24574924
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of BH3 mimetics as a combination therapy with irradiation in head and neck squamous cell carcinoma.
Korelin K; Oostveen M; Wahbi W; Ianevski F; Cavalcante B; Turunen L; Belevich I; Al-Samadi A; Salo T
Biomed Pharmacother; 2024 May; 175():116719. PubMed ID: 38749173
[TBL] [Abstract][Full Text] [Related]
5. Cell Death Induced by the Combination of
Woo SR; Noh JK; Ahn SY; Lee MK; Yu HS; Min S; Kong M; Lee JW; Lee YC; Ko SG; Eun YG
Anticancer Agents Med Chem; 2024; 24(1):50-57. PubMed ID: 37921146
[TBL] [Abstract][Full Text] [Related]
6. Cancer exosomes induce tumor innervation.
Madeo M; Colbert PL; Vermeer DW; Lucido CT; Cain JT; Vichaya EG; Grossberg AJ; Muirhead D; Rickel AP; Hong Z; Zhao J; Weimer JM; Spanos WC; Lee JH; Dantzer R; Vermeer PD
Nat Commun; 2018 Oct; 9(1):4284. PubMed ID: 30327461
[TBL] [Abstract][Full Text] [Related]
7. MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.
Wen Y; Li H; Zeng Y; Wen W; Pendleton KP; Lui VW; Egloff AM; Grandis JR
Oncotarget; 2016 Apr; 7(17):23300-11. PubMed ID: 27004400
[TBL] [Abstract][Full Text] [Related]
8. Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
Bai XY; Zhang XC; Yang SQ; An SJ; Chen ZH; Su J; Xie Z; Gou LY; Wu YL
PLoS One; 2016; 11(3):e0149370. PubMed ID: 26943330
[TBL] [Abstract][Full Text] [Related]
9. FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.
Ji W; Yu Y; Li Z; Wang G; Li F; Xia W; Lu S
Oncotarget; 2016 Mar; 7(12):15118-34. PubMed ID: 26936993
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells of head and neck squamous cell carcinoma; distance towards clinical application; a systematic review of literature.
Sun Q; Chen X; Luo H; Meng C; Zhu D
Am J Cancer Res; 2023; 13(9):4315-4345. PubMed ID: 37818051
[TBL] [Abstract][Full Text] [Related]
11. Myeloid cell leukemia-1 expression in cancers of the oral cavity: a scoping review.
Choi SJ; Swarup N; Shin JA; Hong SD; Cho SD
Cancer Cell Int; 2022 May; 22(1):182. PubMed ID: 35524332
[TBL] [Abstract][Full Text] [Related]
12. Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer.
Bos T; Ratti JA; Harada H
Front Oral Health; 2021; 2():676643. PubMed ID: 35048023
[TBL] [Abstract][Full Text] [Related]
13. ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-Small Cell Lung Cancer Preclinical Model.
Lee JM; Kim HS; Kim A; Chang YS; Lee JG; Cho J; Kim EY
Yonsei Med J; 2022 Jan; 63(1):16-25. PubMed ID: 34913280
[TBL] [Abstract][Full Text] [Related]
14. B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy.
Alam M; Ali S; Mohammad T; Hasan GM; Yadav DK; Hassan MI
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638779
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy.
Ritter V; Krautter F; Klein D; Jendrossek V; Rudner J
Cell Death Dis; 2021 Jul; 12(7):694. PubMed ID: 34257274
[TBL] [Abstract][Full Text] [Related]
16. Combining radiation to EGFR and Bcl-2 blockade: a new approach to target cancer stem cells in head and neck squamous cell carcinoma.
Guy JB; Espenel S; Louati S; Gauthier A; Garcia MA; Vial N; Malésys C; Ardail D; Alphonse G; Wozny AS; Rodriguez-Lafrasse C; Magné N
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1905-1916. PubMed ID: 33791846
[TBL] [Abstract][Full Text] [Related]
17. Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck.
Carter RJ; Milani M; Butterworth M; Alotibi A; Harper N; Yedida G; Greaves G; Al-Zebeeby A; Jorgensen AL; Schache AG; Risk JM; Shaw RJ; Jones TM; Sacco JJ; Hurlstone A; Cohen GM; Varadarajan S
Cell Death Dis; 2019 Dec; 10(12):912. PubMed ID: 31801952
[TBL] [Abstract][Full Text] [Related]
18. Emerging approaches to target mitochondrial apoptosis in cancer cells.
Gilmore A; King L
F1000Res; 2019; 8():. PubMed ID: 31681471
[TBL] [Abstract][Full Text] [Related]
19. Effects of ABT-737 combined with irradiation treatment on uterine cervical cancer cells.
Shen HP; Wu WJ; Ko JL; Wu TF; Yang SF; Wu CH; Yeh CM; Wang PH
Oncol Lett; 2019 Oct; 18(4):4328-4336. PubMed ID: 31579427
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment - Unknown niche with powerful therapeutic potential.
Kolenda T; Przybyła W; Kapałczyńska M; Teresiak A; Zajączkowska M; Bliźniak R; Lamperska KM
Rep Pract Oncol Radiother; 2018; 23(3):143-153. PubMed ID: 29760589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
